BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 20331465)

  • 1. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    Cairo MS; Coiffier B; Reiter A; Younes A;
    Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
    Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
    J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour lysis syndrome: new therapeutic strategies and classification.
    Cairo MS; Bishop M
    Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel.
    Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F
    Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
    Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
    Ann Hematol; 2003 Mar; 82(3):160-5. PubMed ID: 12634948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor lysis syndrome].
    Hagino T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
    Alavi S; Arzanian MT; Abbasian MR; Ashena Z
    Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome.
    Tiu RV; Mountantonakis SE; Dunbar AJ; Schreiber MJ
    Semin Thromb Hemost; 2007 Jun; 33(4):397-407. PubMed ID: 17525897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
    Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor lysis syndrome and clinical guidelines].
    Ishizawa K
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):135-40. PubMed ID: 24743190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management.
    Abu-Alfa AK; Younes A
    Am J Kidney Dis; 2010 May; 55(5 Suppl 3):S1-13; quiz S14-9. PubMed ID: 20420966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence and Risk Assessment of Tumor Lysis Syndrome in Patients with Advanced Germ Cell Cancer].
    Kurobe M; Kawai K; Tanaka K; Ichioka D; Yoshino T; Kandori S; Kawahara T; Waku N; Takaoka E; Kojima T; Joraku A; Suetomi T; Miyazaki J; Nishiyama H
    Hinyokika Kiyo; 2016 May; 62(5):237-42. PubMed ID: 27320114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological emergencies: tumor lysis syndrome.
    Sobota J; Püsküllüoglu M; Zygulska AL
    Przegl Lek; 2014; 71(4):210-4. PubMed ID: 25141580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor lysis syndrome. A life-threatening complication during cytostatic treatment of chemosensitive types of cancer].
    Wibe E; Kvaløy S; Nome O; Abrahamsen AF; Bjørgo S
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2435-7. PubMed ID: 1926084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor lysis syndrome in patients with light chain multiple myeloma: report of two cases.
    Chang H; Lee SY; Tang TC
    Chang Gung Med J; 2011; 34(6 Suppl):70-5. PubMed ID: 22490464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.